Centers For Disease Control And Prevention

This study tested the JYNNEOS smallpox vaccine in 1,600 healthcare workers in the Democratic Republic of the Congo who are at high risk of catching mpox. The goal was to see if the vaccine can prevent mpox infection and is safe to use. Participants received the vaccine and were m…

This early-stage study tested an experimental inactivated rotavirus vaccine (CDC-9) in 50 healthy adults aged 18 to 45. The goal was to see if the vaccine is safe and whether it triggers an immune response. Participants received three shots, and researchers monitored for side eff…

This study looked at how to best dose a combination of two drugs, rifapentine and isoniazid, to prevent tuberculosis (TB) in children up to 12 years old who have latent TB infection (meaning they carry the bacteria but aren't sick). The goal was to find a dose that works as well …

This study tested a short video shown in HIV clinic waiting rooms to help patients start and stay on antiretroviral therapy. Over 4,000 people from clinics serving mostly African American and Hispanic communities took part. The video aimed to improve medication adherence, keep pa…

This study tested a program called PALMS that uses live movement and sound to help African-American and Latino teen boys in juvenile justice or drug treatment centers reduce their risk of getting HIV. The program aimed to lower risky sexual behaviors and encourage HIV testing. Th…

This study looked at whether using alcohol hand sanitizers and face masks, along with educational materials, can reduce the spread of colds and flu among family members. Over 2,700 people from 450 households in New York City took part. Each family was randomly assigned to receive…

This study looked at how two tuberculosis drugs, rifapentine and moxifloxacin, are processed in the body. Researchers took blood samples from 53 adults with TB to measure drug levels and see how they relate to treatment success and side effects. The goal is to improve dosing for …